IQVIA Holdings, Inc. · NYSE:IQV
IQVIA — Q4 2018 Earnings Presentation
14 slides from IQVIA's earnings presentation, Feb 14, 2019
Slide 1: Q4 2018 Earnings Call
Q4 2018 Earnings Call February 14, 2019 Copyright © 2019 IQVIA. All rights reserved.
Slide 2: Legal
Legal This presentation should be viewed in conjunction with IQVIA’s Q4 2018 earnings call Safe Harbor Statement for Forward-Looking Statements This presentation contains “forward-looking statements” within the meaning of the federal securities laws, including Section 27A of the Securities Act of 19
Slide 3: 4th Quarter Results
4th Quarter Results $M, except per share data Revenue Adjusted EBITDA(1) Adjusted Diluted EPS(1) +8.1% CFx +9.7% CFx +23.0% AFx +6.6% AFx +10.8% AFx $1.50 $583 $2,688 $2,521 $526 $1.22 Q4 2018 Q4 2017 Q4 2018 Q4 2017 Q4 2018 Q4 2017 Dollars are at actual foreign exchange rates. AFx is actual currenc
Slide 4: 4th Quarter and Full-Year Revenue
4th Quarter and Full-Year Revenue $M Q4 Full Year VPY% VPY% VPY% VPY% 2018 2017 2018 2017 AFx CFx AFx CFx Technology & Analytics $1,127 $1,036 8.8% 10.9% $4,137 $3,682 12.4% 12.1% Solutions Research & $1,368 $1,269 7.8% 8.7% $5,465 $5,105 7.1% 6.5% Development Solutions Contract Sales & $193 $216 (1
Slide 5: 4th Quarter and Full-Year Profit
4th Quarter and Full-Year Profit $M, except per share data Q4 Full Year 2018 2017 2018 2017 Adjusted EBITDA (1) $583 $526 $2,224 $2,010 Net Income (2) $69 $1,027 $259 $1,277 Diluted Earnings per Share (2) $0.34 $4.79 $1.24 $5.74 Adjusted Net Income (1) $307 $261 $1,156 $1,014 Adjusted Diluted Earnin
Slide 6: R&D Solutions Contracted Services Net New Business
R&D Solutions Contracted Services(1) Net New Business $B 5.85 +28.9% 4.54 LTM Q4 2017 LTM Q4 2018 LTM: Last twelve months. 5 (1) Services New Business excludes reimbursed expenses (i.e. pass through).
Slide 7: 4th Quarter Balance Sheet and Cash Flow Items and Metrics
4th Quarter Balance Sheet and Cash Flow Items and Metrics $M Cash & Cash Equivalents $891 Gross Debt $11,007 Net Debt $10,116 Gross Leverage Ratio (1) 4.9x Net Leverage Ratio (1) 4.5x Net Cash Provided by Operating Activities $417 Capital Expenditures $(138) Free Cash Flow $279 Dollars are at actual
Slide 8: Full-Year 2019 Guidance
Full-Year 2019 Guidance $M, except per share data Revenue $10,900 - $11,125 VPY% 4.7% - 6.8% Adjusted EBITDA $2,375 - $2,425 VPY% 6.8% - 9.0% Adjusted Diluted EPS $6.20 - $6.40 VPY% 11.7% - 15.3% Adjusted Book Tax rate (1) ~22% Adjusted Cash Tax rate (1) ~15% Dollars are at actual foreign exchange r
Slide 9: Full-Year 2019 Segment Revenue Guidance
Full-Year 2019 Segment Revenue Guidance $M 2019 VPY% CFx VPY% Afx Technology & Analytics $4,350 - $4,425 6.7% - 8.6% 5.1% - 7.0% Solutions Research & Development $5,750 - $5,900 6.0% - 8.8% 5.2% - 8.0% Solutions Contract Sales & Medical ~$800 ~flat ~(1.2)% Solutions Revenue $10,900 – $11,125 5.8% -
Slide 10: IQVIA branding closing slide
IMS Health & Quintiles are now VIA
Slide 11: Appendix
IMS Health & Quintiles are now VIA = Appendix 10
Slide 12: Net Income to Adjusted EBITDA Reconciliation
Net Income to Adjusted EBITDA Reconciliation $M 11 Numbers may not add to total due to rounding.
Slide 13: Net Income to Adj. Net Income and Per Share Data Reconciliation
Net Income to Adj. Net Income and Per Share Data Reconciliation $M, except per share data Three Months Ended Year Ended December 31, December 31, 2018 2017 2018 2017 Net Income Attributable to IQVIA Holdings Inc. $ 69 $ 1,027 $ 259 $ 1,277 Provision for (benefit from) income taxes 30 (999) 59 (992)
Slide 14: Leverage Ratios
Leverage Ratios $M Gross Debt, net of Original Issue Discount, as of December 31, 2018 $ 11,007 Net Debt as of December 31, 2018 $ 10,116 Adjusted EBITDA for the year ended December 31, 2018 $ 2,224 Gross Leverage Ratio (Gross Debt/LTM Adjusted EBITDA) 4.9x Net Leverage Ratio (Net Debt/LTM Adjusted